Skip to main content

Design and Construction of Recombinant Vaccinia Viruses

  • Protocol
Recombinant Gene Expression Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 62))

Abstract

The structural and functional analyses of proteins have benefited enormously from the use of technologies of recombinant gene expression. The recombinant vaccinia virus system has been widely employed to express genes from eukaryotic, prokaryotic, and viral origins (for reviews, see refs. 27) and several detailed protocols for the generation, identification, isolation, and characterization of recombinant vaccinia viruses have been published (8-10).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moss, B. (1991) Vaccinia virus: a tool for research and vaccine development. Science 252, 1662–1667.

    Article  PubMed  CAS  Google Scholar 

  2. Smith, G. L. (1991) Vaccinia virus vectors for gene expression. Curr. Open Biotechnol. 2, 713–717.

    Article  CAS  Google Scholar 

  3. Cox, W. L., Tartaglia, J., and Paoletti, E. (1992) Poxvirus recombinants as live vaccines, in Recombinant Poxviruses (Binns, M. M. and Smith, G. L., eds), CRC, Boca Raton, pp. 123–162.

    Google Scholar 

  4. Fenner, F. (1992) Vaccinia virus as a vaccine, and poxvirus pathogenesis, in Recombinant Poxviruses (M. M. Binns and G. L. Smith, eds.), pp. 1–43. CRC, Boca Raton.

    Google Scholar 

  5. Smith, G. L. and Mackett, M. (1992) The design, construction, and use of vaccinia virus recombinants, in Recombinant Poxviruses” (Binns, M. M. and Smith, G. L., eds.), CRC, Boca Raton, pp. 81–122.

    Google Scholar 

  6. Moss, B. (1993) Poxvirus vectors: cytoplasmic expression of transferred genes. Curr. Opin. Gen. Dev. 3, 86–90.

    Article  CAS  Google Scholar 

  7. Moss, B. (1994) Replicating and host-Restricted non-replicating vaccinia virus vectors for vaccine development. Dev. Biol. Stand 82, 55–63.

    PubMed  CAS  Google Scholar 

  8. Earl, P. L., Cooper, N., and Moss, B. (1991) Expression of proteins in mammalian cells using vaccinia viral vectors, in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seldman, J. G., Struhl, J. A., and Struhl, K., eds.), Greene, Wiley Interscience, New York, pp. 16.15.1–16.18.10.

    Google Scholar 

  9. Mackett, M. (1991) Manipulation of vaccinia virus vectors. Gene Transfer Expression Protocols 1, 129–146.

    Article  Google Scholar 

  10. Talavera, A. and Rodriguez, J. M. (1991) Isolation and handling of recombinant vaccinia viruses. Practical Mol. Virol. 8, 235–248.

    Article  CAS  Google Scholar 

  11. Moss, B. (1990) Poxviridae and their replication, in Virology (Fields, B. N., Knipe, D. M., Chanock, R. M., Hirsch, M. S., Melnick, J., Monath, T. P., and Rolzman, B., eds.), Raven, New York, pp. 2079–2112.

    Google Scholar 

  12. Moss, B. (1992) Molecular biology of poxviruses, in Recombinant Poxviruses (Binns, M. M. and Smith, G. L., eds.), CRC, Boca Raton, pp. 45–80.

    Google Scholar 

  13. Moss, B. (1994) Vaccinia virus transcription, in Transcription Mechanisms and Regulation (Conaway, R. C. and Conaway, J. W., eds.), Raven, New York, pp. 185–205.

    Google Scholar 

  14. Mackett, M., Smith, G. L., and Moss, B. (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79, 7415–7419.

    Article  PubMed  CAS  Google Scholar 

  15. Panicali, D. and Paoletti, E. (1982) Construction of poxviruses as cloning vectors insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 79, 4927–4931.

    Article  PubMed  CAS  Google Scholar 

  16. Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122–8126.

    Article  PubMed  CAS  Google Scholar 

  17. Fuerst, T. R., Earl, P. L., and Moss, B. (1987) Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell Biol. 7, 2538–2544.

    PubMed  CAS  Google Scholar 

  18. Elroy-Stein, O. and Moss, B. (1992) Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system, in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seldman, J. G., Smith, J. A., and Struhl, K., eds.), Greene, Wiley Interscience, New York, pp. 16.

    Google Scholar 

  19. Rodriguez, D., Zhou, Y., Rodriguez, J.-R., Durbin, R. K., Jiminez, V., McAllister, W. T., and Esteban, M. (1990) Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors. J. Virol. 64, 4851–4857.

    PubMed  CAS  Google Scholar 

  20. Usdin, T. B., Brownstein, M. J., Moss, B., and Isaacs, S. N. (1993) SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture. Biotechniques 14, 222–224.

    PubMed  CAS  Google Scholar 

  21. Fuerst, T. R., Fernandez, M. P., and Moss, B. (1989) Transfer of the inducible lac repressor/operator system from Escherichia coli a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86, 2549–2553.

    Article  PubMed  CAS  Google Scholar 

  22. Rodriguez, J. F. and Smith, G. L. (1990) Inducible gene expression from vaccinia virus vectors. Virology 177, 239–250.

    Article  PubMed  CAS  Google Scholar 

  23. Alexander, W. A., Moss, B., and Fuerst, T. R. (1992) Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia colilac repressor. J. Virol. 66, 2934–2942.

    PubMed  CAS  Google Scholar 

  24. Cullen, B. R. and Garrett, E. D. (1992) A comparison of regulatory features in primate lentiviruses. AIDS Res. Hum. Retroviruses 8, 387–393.

    Article  PubMed  CAS  Google Scholar 

  25. Stomatos, N., Chakrabarti, S., Moss, B., and Hare, D. J. (1987) Expression of polyomavirus virion proteins by a vaccinia virus vector association of VP1 and VP2 with the nuclear framework. J. Biol. 61, 516–525.

    Google Scholar 

  26. Merchinsky, M. and Moss, B. (1992) Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation recombination-independent selectable cloning vectors. Virology 190, 522–526.

    Article  Google Scholar 

  27. Scheiflinger, F., Dorner, F., and Falkner, F. G. (1992) Construction of chimeric vaccinia viruses by molecular cloning and packaging. Proc. Natl. Acad. Sci. USA 89, 9977–9981.

    Article  PubMed  CAS  Google Scholar 

  28. Davison, A. J. and Moss, B. (1990) New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Res. 18, 4285, 4286.

    Article  PubMed  CAS  Google Scholar 

  29. Broder, C. C. and Berger, E. A. (1993) CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodefieciency virus type 1 envelope glycoprotein-mediated cell fusion. J. Biol. 67, 913–926.

    CAS  Google Scholar 

  30. Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., and Moss, B. (1994) Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68, 3015–3026.

    PubMed  CAS  Google Scholar 

  31. Zhang, Y. and Moss, B. (1991) Inducer-dependent conditional-lethal mutant animal viruses. Proc. Natl. Acad. Sci. USA 88, 1511–1515.

    Article  PubMed  CAS  Google Scholar 

  32. Yuen, L. and Moss, B. (1987) Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. USA 84, 6417–6421.

    Article  PubMed  CAS  Google Scholar 

  33. Earl, P. L., Hugen, A. W., and Moss, B. (1990) Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J. Virol. 64, 2448–2451.

    PubMed  CAS  Google Scholar 

  34. Broder, C. C., Kennedy, P. E., Michaels, F., and Berger, E. A. (1994) Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 142, 167–174.

    Article  PubMed  CAS  Google Scholar 

  35. Cook, D. G., Lee, V.M.-Y., and Doms, R. W. (1994) Expression of foreign proteins in a human neuronal system. Methods Cell Biol. 43, 289–303.

    Article  PubMed  CAS  Google Scholar 

  36. Chakrabarti, S., Brechling, K., and Moss, B. (1985) Vaccinia virus expression vector coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell Biol. 5, 3403–3409.

    PubMed  CAS  Google Scholar 

  37. Ramshaw, I. A., Andrew, M. E., Philips, S. M., Boyle, D. B., and Coupar, B. E. H. (1987) Recovery of immunodeficient mice from a vaccinia virus/IL2 recombinant infection. Nature 329, 545–546.

    Article  PubMed  CAS  Google Scholar 

  38. Boyle, D. B. and Coupar, B. E. H. (1988) A dominant selectable marker for the construction of recombinant poxviruses. Gene 65, 123–128.

    Article  PubMed  CAS  Google Scholar 

  39. Falkner, F. G. and Moss, B. (1988) Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62, 1849–1854.

    PubMed  CAS  Google Scholar 

  40. Isaacs, S. N., Kotwal, G. J., and Moss, B. (1990) Reverse guanine phosphoribosyl-transferase selection of recombinant vaccinia viruses. Virology 178, 626–630.

    Article  PubMed  CAS  Google Scholar 

  41. Falkner, F. G. and Moss, B. (1990) Transient dominant selection of recombinant vaccinia verses. J. Virol. 64, 3108–3111.

    PubMed  CAS  Google Scholar 

  42. Franke, C. A., Rice, C. M., Strauss, J. H., and Hruby, D. E. (1985) Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Mol. Cell Biol. 5, 1918–1924.

    PubMed  CAS  Google Scholar 

  43. Zhou, J., Crawford, L., Sun, X.-Y., and Frazer, I. H. (1991) The hygromycin-resistance-encoding gene as a selection marker for vaccinia virus recombinants. Gene 107, 307–312.

    Article  PubMed  CAS  Google Scholar 

  44. Rodriguez, J. F. and Esteban, M. (1989) Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants. J. Virol. 63, 997–1001.

    PubMed  CAS  Google Scholar 

  45. Blasco, R. and Moss, B. (1995) Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158, 157–162.

    Article  PubMed  CAS  Google Scholar 

  46. Shida, H., Tochikura, T., Sato, T.K. Hirayoshi K., Seki, M., Ito, Y., Hatanaka, M., Hinuma, Y., Sugimoto, M., Takahashi-Nishimaki, F., Marayama, T., Miki, K., Suzuki, K., Morita, M., Sashiyama, H., and Hayami, M. (1987) Effect of the recombinant vaccinia viruses that express HTLV-1 envelope gene on HTLV-1 infection. EMBO J. 6, 3379–3384.

    PubMed  CAS  Google Scholar 

  47. Perkus, M. E., Limbach, K., and Paoletti, E. (1989) Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63, 3829–3836.

    PubMed  CAS  Google Scholar 

  48. Boyle, M. D. P. and Reis, K. J. (1987) Bacterial Fc receptors. Biotechnology 5, 697–703.

    Article  CAS  Google Scholar 

  49. Sutter, G., Wyatt, L. S., Foley, P. L., Bennink, J. R., and Moss, B. (1994) A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12, 1032–1040.

    Article  PubMed  CAS  Google Scholar 

  50. Chen, H. and Padmanabhan, R. (1994) A modified method for isolation of recombinant vaccinia virus. BioTechniques 17, 41–42.

    Google Scholar 

  51. Mackett, M., Smith, G. L., and Moss, B. (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49, 857–864.

    PubMed  CAS  Google Scholar 

  52. Flexner, C., Hugin, A., and Moss, B. (1987) Prevention of vaccinia virus infectron in immunodeficient nude mice by vector-directed IL-2 expression. Nature 330, 259–262.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Humana Press Inc.

About this protocol

Cite this protocol

Broder, C.C., Earl, P.L. (1997). Design and Construction of Recombinant Vaccinia Viruses. In: Tuan, R.S. (eds) Recombinant Gene Expression Protocols. Methods in Molecular Biology, vol 62. Humana Press. https://doi.org/10.1385/0-89603-480-1:173

Download citation

  • DOI: https://doi.org/10.1385/0-89603-480-1:173

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-480-8

  • Online ISBN: 978-1-59259-548-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics